Hospital
North Broward Hospital District
North Broward Hospital District was paid $10.50M by Medicaid between Jan 2018 and Dec 2024, across 202 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoNORTH BROWARD HOSPITAL DISTRICT
POMPANO BEACH, FL 33064
POMPANO BEACH, FL 33064
33aNPI1376571323assigned 06/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.50M
24GClaims533,935
24DCodes billed202
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#49 of 163
Median peer was paid$4.77M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BERT, ALISA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,104 | $699K | |
| 2019 | 112,153 | $1.33M | |
| 2020 | 83,641 | $1.27M | |
| 2021 | 103,075 | $1.75M | |
| 2022 | 107,261 | $2.58M | |
| 2023 | 61,148 | $1.94M | |
| 2024incomplete | 27,553 | $935K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 22,794 | 19,551 | $1.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 22,919 | 20,676 | $1.73M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 12,765 | 10,105 | $780K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.1% | 8,941 | 6,629 | $639K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.9% | 5,884 | 4,693 | $512K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 2,837 | 2,474 | $417K |
| 36415 | Collection of venous blood by venipuncture | 4.0% | 42,850 | 26,191 | $415K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 5,051 | 4,550 | $329K |
| G0378 | Hospital observation service, per hour | 2.1% | 12,390 | 5,893 | $224K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.0% | 4,486 | 3,364 | $212K |
| 80053 | Comprehensive metabolic panel | 2.0% | 32,983 | 24,045 | $209K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 1,555 | 1,346 | $197K |
190 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 14,131 | $194K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 3,462 | $185K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.6% | 3,959 | $164K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 48,278 | $143K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.3% | 786 | $134K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 2,088 | $134K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 3,111 | $126K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 5,552 | $125K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 10,010 | $118K |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 1.1% | 508 | $117K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,604 | $89K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12,979 | $88K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,673 | $70K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 724 | $58K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 526 | $48K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,809 | $44K |
| 87070 | <1% | 2,777 | $43K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,628 | $43K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 545 | $43K |
| 71045 | Radiologic examination, chest; single view | <1% | 16,468 | $42K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,134 | $39K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,974 | $38K |
| 85610 | <1% | 10,916 | $36K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,637 | $34K |
| 81025 | <1% | 3,674 | $33K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,242 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,340 | $32K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 349 | $31K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 630 | $31K |
| 85730 | <1% | 9,808 | $30K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,508 | $30K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 596 | $30K |
| 97161 | <1% | 1,249 | $30K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 481 | $29K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,241 | $29K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 8,962 | $29K |
| 83735 | <1% | 6,522 | $28K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,475 | $26K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,734 | $23K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,446 | $22K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,467 | $21K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,274 | $19K |
| 84484 | <1% | 8,729 | $18K | |
| 81001 | <1% | 13,890 | $17K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 248 | $15K |
| 86850 | <1% | 2,967 | $14K | |
| 73030 | <1% | 886 | $13K | |
| 73610 | <1% | 756 | $13K | |
| 36430 | <1% | 209 | $13K | |
| 73564 | <1% | 1,211 | $12K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,638 | $11K |
| 73130 | <1% | 614 | $11K | |
| 81003 | <1% | 1,932 | $11K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 794 | $10K |
| 80061 | Lipid panel | <1% | 1,770 | $10K |
| 86900 | <1% | 3,450 | $10K | |
| 97116 | <1% | 1,135 | $10K | |
| 86901 | <1% | 3,448 | $9K | |
| 93970 | <1% | 147 | $9K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,672 | $9K |
| 96367 | <1% | 423 | $9K | |
| 73630 | <1% | 925 | $8K | |
| A9270 | Non-covered item or service | <1% | 2,044 | $8K |
| J3490 | Unclassified drugs | <1% | 840 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 492 | $7K |
| 74018 | <1% | 756 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 175 | $7K |
| 84702 | <1% | 2,504 | $7K | |
| 96415 | <1% | 182 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 226 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,606 | $6K |
| 93971 | <1% | 387 | $5K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,787 | $5K |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 1,304 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,918 | $5K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 19 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 299 | $5K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 36 | $5K |
| 83880 | <1% | 2,260 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,134 | $5K |
| 96417 | <1% | 287 | $5K | |
| 73110 | <1% | 297 | $4K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 15 | $4K |
| 87077 | <1% | 1,031 | $4K | |
| 72100 | <1% | 511 | $4K | |
| 72170 | <1% | 460 | $4K | |
| 97162 | <1% | 202 | $4K | |
| 12011 | <1% | 51 | $4K | |
| 72131 | <1% | 196 | $4K | |
| 83690 | <1% | 5,626 | $4K | |
| 87210 | <1% | 604 | $4K | |
| 71250 | <1% | 75 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 291 | $3K |
| 87430 | <1% | 2,224 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 901 | $3K |
| 84703 | <1% | 6,139 | $3K | |
| 74019 | <1% | 342 | $3K | |
| 87040 | <1% | 2,533 | $3K | |
| 87186 | <1% | 1,614 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 126 | $2K |
| 82728 | <1% | 530 | $2K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 15 | $2K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 179 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,543 | $2K |
| 83605 | <1% | 1,776 | $2K | |
| 73502 | <1% | 249 | $2K | |
| 73140 | <1% | 27 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 941 | $1K |
| 82550 | <1% | 2,169 | $1K | |
| 85379 | <1% | 1,257 | $1K | |
| 76641 | <1% | 15 | $1K | |
| 86140 | <1% | 3,016 | $1K | |
| 82553 | <1% | 291 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 566 | $1K |
| J1815 | Injection, insulin, per 5 units | <1% | 94 | $1K |
| 82607 | <1% | 160 | $1K | |
| 12002 | <1% | 28 | $998.01 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,029 | $957.12 |
| 82746 | <1% | 75 | $954.57 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 171 | $953.64 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,213 | $948.40 |
| 83540 | <1% | 82 | $939.26 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 719 | $932.72 |
| 73590 | <1% | 103 | $931.65 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 260 | $909.07 |
| P9051 | Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit | <1% | 32 | $905.66 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 263 | $897.92 |
| 90714 | <1% | 462 | $855.85 | |
| 74022 | <1% | 330 | $769.56 | |
| 84100 | <1% | 596 | $709.17 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 123 | $699.65 |
| 93976 | <1% | 28 | $678.92 | |
| 87088 | <1% | 985 | $513.05 | |
| 88312 | <1% | 552 | $451.82 | |
| 88313 | <1% | 704 | $431.65 | |
| 87631 | <1% | 13 | $407.26 | |
| 87205 | <1% | 290 | $405.24 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 578 | $353.75 |
| 93017 | <1% | 34 | $338.88 | |
| 85652 | <1% | 61 | $328.41 | |
| 84132 | <1% | 302 | $286.99 | |
| 82150 | <1% | 283 | $254.63 | |
| 83550 | <1% | 46 | $240.78 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 976 | $165.41 |
| 93975 | <1% | 14 | $161.79 | |
| 72040 | <1% | 12 | $109.52 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 13 | $97.00 |
| 95816 | <1% | 23 | $76.94 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 215 | $75.00 |
| 85651 | <1% | 65 | $67.41 | |
| 00731 | <1% | 113 | $35.83 | |
| 90686 | <1% | 65 | $29.93 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | <1% | 51 | $28.48 |
| 80329 | <1% | 38 | $25.26 | |
| 80320 | <1% | 68 | $15.54 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 43 | $13.32 |
| 86300 | <1% | 21 | $12.56 | |
| 84439 | <1% | 15 | $7.68 | |
| 82533 | <1% | 45 | $7.20 | |
| 84436 | <1% | 68 | $3.60 | |
| 85046 | <1% | 43 | $1.76 | |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 56 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 112 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 356 | $0.00 |
| 90715 | 0% | 31 | $0.00 | |
| 00811 | 0% | 16 | $0.00 | |
| 10060 | 0% | 12 | $0.00 | |
| 85007 | 0% | 13 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 133 | $0.00 |
| A4212 | Non-coring needle or stylet with or without catheter | 0% | 38 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 16 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 41 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 0% | 43 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 105 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 28 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 59 | $0.00 |
| 73090 | 0% | 13 | $0.00 | |
| 96376 | 0% | 354 | $0.00 | |
| 73560 | 0% | 19 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 24 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 19 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 100 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 33 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 16 | $0.00 |
| 00813 | 0% | 28 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 35 | $0.00 |
| 87147 | 0% | 19 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 25 | $0.00 |
| 85027 | 0% | 25 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERT, ALISA (INTERIM CFO)
Parent organizationNORTH BROWARD HOSPITAL DISTRICT
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.